| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | paclitaxel | gCSI | pan-cancer | AAC | -0.15 | 0.005 |
| mRNA | GDC-0941 | gCSI | pan-cancer | AAC | -0.17 | 0.006 |
| mRNA | Rapamycin | gCSI | pan-cancer | AAC | -0.15 | 0.006 |
| mRNA | Docetaxel | gCSI | pan-cancer | AAC | -0.14 | 0.01 |
| mRNA | Gemcitabine | gCSI | pan-cancer | AAC | -0.12 | 0.03 |
| mRNA | thapsigargin | gCSI | pan-cancer | AAC | -0.099 | 0.08 |
| mRNA | Crizotinib | gCSI | pan-cancer | AAC | -0.098 | 0.08 |
| mRNA | Vorinostat | gCSI | pan-cancer | AAC | 0.07 | 0.2 |
| mRNA | lapatinib | gCSI | pan-cancer | AAC | -0.069 | 0.2 |
| mRNA | MS-275 | gCSI | pan-cancer | AAC | -0.047 | 0.4 |